United States · Bill · S
S. 975 (109th)
Project BioShield II Act of 2005
Introduced
28 April 2005
Last action
—
Status
Committee on Health, Education, Labor, and Pensions. Held a roundtable discussion of the bill.
Sponsors
—
Subjects
Discovery layer
Source updated
15 August 2025
Summary
Project BioShield II Act of 2005 - Establishes: (1) the Terrorism and Infectious Disease Countermeasure Purchase Fund; (2) procurement pools for qualified countermeasures and security countermeasures; (3) the International Public Health Advisory Committee to develop strategies for establishing such pools; (4) the Office of Public Health Countermeasure Development within the Department of Health and Human Services (HHS) ; (5) the Office of Medical Readiness within the Office of the Secretary of the Department of Homeland Security (DHS) to assume functions of the National Disaster Medical System and the Metropolitan Medical Response System; (6) the National Emergency Medical Readiness and Response Board within DHS to oversee emergency medical response plans; (7) the National Center for Healthcare Technology Development to manage NIH intellectual property; (8) the Millennium Medicine Discovery Award; (9) the Office of the Deputy Commissioner for Biological, Chemical, Nuclear, Radiological and Infectious Disease Products; and (10) the Global Disease Detection Trust Fund. Creates incentives for the development of countermeasures, including: (1) payments to manufacturers; (2) accelerated approval of countermeasures; (3) patent term restoration and extension; (4) exclusive marketing; (5) federal tax incentives; (6) reimbursements for production costs; (7) expedited processing of visa applications; (8) grants and contracts for the construction and management of biosafety level 3-4 facilities; and (9) grants and scholarships for personnel to conduct biodefense and infectious disease research. Sets forth provisions regarding necessary research for countermeasure development, including research regarding: (1) diagnostics; (2) detection technology; (3) infectious diseases; (4) accurate animal models; (5) biologics; (6) vaccine adjuvants; (7) the production of cell culture; (8) vaccines; (9) zoonotic disease surveillance; and (10) agroterrorism research. Bioshield Export Priority Act - Requires the Secretary of Commerce or the Secretary of Health and Human Services to expedite the processing of requests to export restricted items necessary to procure countermeasures.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Placed on Calendar Senate (text)
Placed on Calendar Senate · EN · 9 May 2005
Placed on Calendar Senate (PDF)
Placed on Calendar Senate · EN · 9 May 2005
Introduced in Senate (text)
Introduced in Senate · EN · 29 April 2005
Introduced in Senate (PDF)
Introduced in Senate · EN · 29 April 2005
Introduced in Senate
summary · EN · 28 April 2005
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/senate-bill/975
- Open data entity: https://api.congress.gov/v3/bill/109/s/975